Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

doi:10.1186/1475-2867-9-9

Cancer Cell International

Volume 9

Viewing options:

Associated material:

Related literature:

Articles citing this article
on Google Scholar
on PubMed Central
Other articles by authors
on Google Scholar

Tsui SM
Lam WM
Lam TL
Chong HC
So PK
Kwok SY
Arnold S
Cheng PN
Wheatley DN
Lo WH
Leung YC

on PubMed

Tsui SM
Lam WM
Lam TL
Chong HC
So PK
Kwok SY
Arnold S
Cheng PN
Wheatley DN
Lo WH
Leung YC
Related articles/pages
on Google

on Google Scholar

on PubMed

Tools:

Post to:

Email this article to a friend

Pegylated derivatives of recombinant human arginase (rhArg1) for sustained in vivo activity in cancer therapy: preparation, characterization and analysis of their pharmacodynamics in vivo and in vitro and action upon hepatocellular carcinoma cell (HCC)

Sam-Mui Tsui , Wai-Man Lam , Tin-Lun Lam , Hiu-Chi Chong , Pui-Kin So , Sui-Yi Kwok , Simon Arnold , Paul Ning-Man Cheng , Denys N Wheatley , Wai-Hung Lo and Yun-Chung Leung

Cancer Cell International 2009, 9:9doi:10.1186/1475-2867-9-9

Your name*
Your email address*
Recipient's email address*	(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:	I thought the following article from Cancer Cell International (http://www.cancerci.com/home) would be of interest to you.